Evidence map›Paper›PMID 34928497›Full record

ArticleThe Journal of pathology2022

5-Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia.

Diya B Joseph, Gervaise H Henry, Alicia Malewska, Jeffrey C Reese, Ryan J Mauck, Jeffrey C Gahan, Ryan C Hutchinson, James L Mohler, Claus G Roehrborn, Douglas W Strand

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Diya B JosephDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0002-0587-9558
Gervaise H HenryDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0001-7772-9578
Alicia MalewskaDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0002-1966-6035
Jeffrey C ReeseSouthwest Transplant Alliance, Dallas, TX, USA.
Ryan J MauckDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0001-6385-5397
Jeffrey C GahanDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0003-1135-0586
Ryan C HutchinsonDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0002-2413-8835
James L MohlerRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID 0000-0002-7726-3795
Claus G RoehrbornDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0003-4024-7369
Douglas W StrandDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, 75390, USA.ORCID 0000-0002-0746-927X
Southwestern Medical Center · USNorth Texas Regional Center for Innovation and Commercialization · USRoswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MELANIE H. COBB · 2010 to 2026
$53.7M
Role of Beta-Catenin in Urinary DysfunctionU54DK104310 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RICKE, WILLIAM A · 2014 to 2023
$12.8M
Notch-mediated 5ARI resistance in human BPHR01DK115477 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI STRAND, DOUGLAS WILLIAM · 2018 to 2022
$1.9M
NCI NIH HHS P30 CA016056NCI NIH HHS P30 CA142543NIDDK NIH HHS R01 DK115477NIDDK NIH HHS U54 DK104310
6 · The paper itself

Abstract

Benign prostatic hyperplasia (BPH) is a progressive expansion of peri-urethral prostate tissue common in aging men. Patients with enlarged prostates are treated with 5-alpha reductase inhibitors (5ARIs) to shrink prostate volume by blocking the conversion of testosterone to dihydrotestosterone (DHT). A reduction in DHT levels can elicit atrophy and apoptosis of prostate secretory luminal cells, which results in a favorable clinical response characterized by improved lower urinary tract symptoms. However, the histologic response to 5ARI treatment is often heterogeneous across prostate acini and lower urinary tract symptoms can persist to require surgical intervention. We used two spatial profiling approaches to characterize gene expression changes across histologically normal and atrophied regions in prostates from 5ARI-treated men. Objective transcriptomic profiling using the Visium spatial gene expression platform showed that 5ARI-induced atrophy of prostate luminal cells correlated with reduced androgen receptor signaling and increased expression of urethral club cell genes including LTF, PIGR, OLFM4, SCGB1A1, and SCGB3A1. Prostate luminal cells within atrophied acini adapted to decreased DHT conditions by increasing NF-κB signaling and anti-apoptotic BCL2 expression, which may explain their survival. Using GeoMx digital spatial profiling with a probe set to assess ~18 000 RNA targets, we confirmed that atrophied acini expressing SCGB3A1 displayed higher levels of club cell markers compared with histologically normal acini with NKX3-1 expression. In addition, club-like cells within regions of 5ARI-induced atrophy closely resembled true club cells from the prostatic urethra. A comparison of histologically normal regions from 5ARI-treated men and histologically normal regions from untreated men revealed few transcriptional differences. Taken together, our results describe a heterogeneous response to 5ARI treatment where cells in atrophied acini undergo an adaptation from a prostate secretory luminal to a club cell-like state in response to 5ARI treatment. © 2021 The Pathological Society of Great Britain and Ireland.

Indexed as

Lower Urinary Tract SymptomsProstatic Hyperplasia5-alpha Reductase InhibitorsAtrophyDihydrotestosteroneHumansMaleProstate5-alpha Reductase InhibitorsDihydrotestosterone5-alpha reductase inhibitorbenign prostatic hyperplasiaclub cellluminal epitheliaspatial transcriptomics

Identifiers

PMID34928497
PMCPMC8930464
OpenAlexW4200416514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.